Skip to content

Amador Bioscience

Active Private limited companyfounded 2022active for 4 yearsHendrik van Veldekesingel 150, 3500 HasseltKBO/BCE: BE 0779.966.013

Lifetime

4 annual accounts with figures on one time axis
peak of €2.3m in 2025
€2.3m▲ €2.5m
lowest -€1.2m in 2023
€267,760▲ €1.2m
peak of -€532,406 in 2022
-€2.3m▲ €267,760
€3.5m▲ 16.1%
peak of 8.6 FTE in 2023
-not published
Board6 names since 2022
4 directors and 3 others
Documentsfilings and deeds
21-06-202640 days before the deadline
2025micro format
Gross margin from -€201,554 to €2.3mProfit of €267,760, after a loss3 directors appointed 16-12New day-to-day manager 24-10Registered office moved within Hasselt 22-01Debts from €3.1m to €3.5m

Key points

from the 2025 annual accounts

Equity

-€2.3m
2022202320242025

Debts exceed assets in financial year 2025.

Result

€267,760 €267,760
-€900,0002024€268,0002025

Back in profit in 2025, after a loss of €899,719 in 2024.

Debts

€3.5m 291% of the balance sheet
Financial debts 79%Suppliers 18%Taxes and wages 2%

Of this, €722,133 falls due within a year.

Liquidity

1.61 was 0.12 in 2024

Short-term debts fell from €3.0m to €722,133.

Position in the sector

-191.5%

Lower solvency than 95% of companies in research and development. Sector median 59.8% · 666 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 823 companies had the same profile as Amador Bioscience has now. Each dot stands for 3 companies, two years later.

91.9%
were still trading
3.6%
stopped another way
2.9%
went bankrupt
  • Small
  • negative equity
  • a profit of 5% of the balance sheet or more
  • without age

Another 1.6% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 823 companies, not a prediction for Amador Bioscience. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Director
  • 1,000 sharesdeed of 13-01-2022
Board & ownership

Recent changes

(director) and (day-to-day manager) resign General meeting of 03-07-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0779966013
3 directors appointed , and · General meeting of 01-12-2025 · Gazette deed
New day-to-day manager appointed, resigned · Board meeting of 29-04-2025 · Gazette deed
All 15 events

Comparable companies

same main activity, similar in size and age
Company
Amador Bioscience Hasselt €1.2m €2.3m -191.5% -
NOVALIX BELGIUM Braine-l'Alleud €1.6m €3.2m 11.9% 36.3
CELL-CELL BIO Ghent €1.0m €0.8m 59.4% -
ILiAD Biotechnologies Ghent €1.1m €1.4m 2.4% 14.4
TECFIT Trooz €1.1m €0.6m 65.1% -
Xper Research Oudenaarde €1.1m €1.3m 41.7% 9.7
Axis44 Jodoigne €2.4m €2.1m 91.6% -

These companies have the same main activity as Amador Bioscience: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €991,000 and €2.4m, founded between 2020 and 2023.

Official details

Source: KBO
Status
Active since 11-01-2022Normal situation
Registered office
177 active companies are registered at this address4 started in the 12 months before. Source: KBO register, as of 18 November 2026.
Activity
Research and development on biotechnologyNACE 72101and 3 others
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2023
Establishment unit
2.328.347.2203500 Hasselt, since 11-01-2022
Financial year end
31 December
Peppol
Reachable since 07-05-2026
Company details

Annual accounts 2025

≈ €4.1mestimated
€1.2m▲ 167%
≈ 5.1 FTEestimated
Filing
Filed on 21-06-2026, 40 days before the end of the filing period
Financials

Insights on Amador Bioscience

Amador Bioscience files the micro format. That format states no turnover. The gross margin rose from -€162,734 in 2022 to €2.3m in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Amador Bioscience

What is the company number of Amador Bioscience?
The company number of Amador Bioscience is 0779.966.013. The VAT number is the same number with BE in front: BE 0779.966.013.
Where is Amador Bioscience based?
The registered office is at Hendrik van Veldekesingel 150, 3500 Hasselt.Company details
What does Amador Bioscience do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Amador Bioscience?
Amador Bioscience is a private limited company (BV).
When was Amador Bioscience founded?
Amador Bioscience was founded on 11-01-2022.
Is Amador Bioscience still active?
Yes, Amador Bioscience is an active enterprise in the KBO register.
How many employees does Amador Bioscience have?
Amador Bioscience had an average of 8.6 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does Amador Bioscience fall under?
In its 2023 annual accounts, Amador Bioscience states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of Amador Bioscience?
The turnover in financial year 2025 is ≈ €4.1m. This figure is estimated from the gross margin of €2.3m and 77 comparable companies of the same size. It probably lies between €2.7m and €5.5m. It is a rough estimate.
Is Amador Bioscience profitable?
In financial year 2025, Amador Bioscience made a profit of €267,760.
Where can I find the annual accounts of Amador Bioscience?
Amador Bioscience filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Amador Bioscience due?
Amador Bioscience must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.